Interstitial Lung Disease (ILD) refers to a group of over 200 chronic lung disorders that cause inflammation and scarring (fibrosis) of the lung’s interstitial tissue – the space around the air sacs. This damage makes it difficult for oxygen to pass into the bloodstream, leading to progressive breathing problems. Common causes include autoimmune diseases (like rheumatoid arthritis or scleroderma), environmental exposures, certain medications, and in many cases, the cause remains unknown (idiopathic pulmonary fibrosis – IPF).

Symptoms of ILD include persistent dry cough, shortness of breath (especially during exertion), fatigue, chest discomfort, and clubbing of fingers. These symptoms often worsen gradually and may significantly affect a patient’s quality of life.

At our hospital, we offer comprehensive diagnosis and management of ILD through a multidisciplinary team of pulmonologists, rheumatologists, radiologists, and physiotherapists. Diagnosis involves a detailed clinical evaluation, high-resolution CT (HRCT) scans of the chest, pulmonary function tests (PFTs), blood tests, and sometimes lung biopsy.

While there is no cure for most forms of ILD, early diagnosis and proper management can slow the progression of the disease and improve quality of life. Treatment options include corticosteroids and antifibrotic medications (like pirfenidone or nintedanib), depending on the type of ILD. Immunosuppressants may be used in autoimmune-related cases. Oxygen therapy, pulmonary rehabilitation, and lifestyle modifications such as smoking cessation are also key components of care.

In advanced cases, lung transplantation may be considered.

Our goal is to provide personalized and compassionate care that helps patients manage symptoms, maintain lung function, and lead an active life. With regular follow-ups and expert guidance, we are committed to supporting every ILD patient at every stage of their journey.